Invasive fungal infections in patients with systemic lupus erythematosus

Journal of Rheumatology

Volumn 39, Issue 9, 2012, Pages 1814-1818

  Martínez Martínez, Marco Ulises ^a   Herrera Van Oostdam, David ^a   Román Acosta, Susana ^a   Magaña Aquino, Martín ^a   Baranda Cándido, Lourdes ^a   Abud Mendoza, Carlos ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

Author keywords

Infections; Invasive fungal infections; Systemic lupus erythematosus

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS; BLOOD CULTURE; CANDIDA; CASE CONTROL STUDY; CLINICAL ARTICLE; COCCIDIOIDES IMMITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE DURATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG PULSE THERAPY; FEMALE; HEMODIALYSIS; HISTOPLASMA CAPSULATUM; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MALE; MORTALITY; MUCOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC MYCOSIS; TREND STUDY;

ADULT; ANTIFUNGAL AGENTS; C-REACTIVE PROTEIN; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MYCOSES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84865793873     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.111498     Document Type: Article

References (22)

1. Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C, et al. Infections and treatment of patients with rheumatic diseases. Clin Exp Rheumatol 2008;26:S67-73.
2. Bouza E, Moya JG, Munoz P. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect Dis Clin North Am 2001;15:335-61, vii.
3. Chen HS, Tsai WP, Leu HS, Ho HH, Liou LB. Invasive fungal infection in systemic lupus erythematosus: An analysis of 15 cases and a literature review. Rheumatology 2007;46:539-44.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
5. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
8. Kim HJ, Park YJ, Kim WU, Park SH, Cho CS. Invasive fungal infections in patients with systemic lupus erythematosus: Experience from affiliated hospitals of Catholic University of Korea. Lupus 2009;18:661-6.
9. Staples PJ, Gerding DN, Decker JL, Gordon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974;17:1-10.
10. Al-Rayes H, Al-Swailem R, Arfin M, Sobki S, Rizvi S, Tariq M. Systemic lupus erythematosus and infections: A retrospective study in Saudis. Lupus 2007;16:755-63.
11. Sipsas NV, Kontoyiannis DP. Invasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents 2012 Feb 13. [E-pub ahead of print]
12. Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 2000;43:1801-8.
13. Ritter ML, Pirofski L. Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. Transpl Infect Dis 2009;11:290-7.
14. Charfeddine K, Zaghden S, Kharrat M, Kamoun K, Jarraya F, Hachicha J. Infectious complications in kidney transplant recipients: A single-center experience. Transplant Proc 2005;37:2823-5.
15. Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 2011;20:588-97.
16. Kim HA, Jeon JY, An JM, Koh BR, Suh CH. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin. J Rheumatol 2012;39:728-34.
17. Sun HY, Singh N. Antimicrobial and immunomodulatory attributes of statins: Relevance in solid-organ transplant recipients. Clin Infect Dis 2009;48:745-55.
18. Viasus D, Gudiol C, Fernandez-Sabe N, Cabello I, Garcia-Vidal C, Cisnal M, et al. Effect of statins on outcomes in immunosuppressed patients with bloodstream infection. Eur J Clin Microbiol Infect Dis 2011;30:77-82.
19. Ippolito A, Petri M. An update on mortality in systemic lupus erythematosus. Clin Exp Rheumatol 2008;26:S72-9.
20. Weng CT, Lee NY, Liu MF, Weng MY, Wu AB, Chang TW, et al. A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan. Lupus 2010;19:1204-9.
21. Martinez-Martinez MU, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus 2011;20:568-74.
22. Jesus A, Liphaus B, Silva C, Bando S, Andrade L, Coutinho A, et al. Complement and antibody primary immunodeficiency in juvenile systemic lupus erythematosus patients. Lupus 2011;20:1275-84.